HAE

Haemonetics Corporation

Healthcare›Medical - Instruments & Supplies|New York Stock Exchange|US

Price

$56.83

Market Cap

$2.66B

Beta

0.31

P/E

16.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-4.02%

EPS Growth (YoY)+42.91%

Revenue CAGR 3Y+5.29%

P/E Ratio16.4

PEG Ratio0.36

FCF Yield+11.58%

Debt / Equity1.34

Interest Coverage12.7x

No credit card required

Already have an account? Sign in to view the full analysis for HAE.